Company Filing History:
Years Active: 1998
Title: Anja Frohlich: Innovator in Oligonucleotide Technology
Introduction
Anja Frohlich is a prominent inventor based in Illerkirchberg, Germany. She has made significant contributions to the field of oligonucleotide technology, particularly in the development of compounds that enhance the stability and functionality of nucleic acids. Her work has implications for therapeutic applications, showcasing her innovative spirit and dedication to scientific advancement.
Latest Patents
Anja Frohlich holds one patent related to her research. The patent focuses on oligonucleotide analogs with terminal 3'-3' or 5'-5' internucleotide linkages. These therapeutically utilizable oligonucleotides are designed to be stable against nucleases, effectively suppressing the biological function of nucleic acids. This innovation represents a significant step forward in the development of nucleic acid-based therapies.
Career Highlights
Throughout her career, Anja has been associated with Hoechst Aktiengesellschaft, a leading company in the pharmaceutical and biotechnology sectors. Her role at the company has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in oligonucleotide technology.
Collaborations
Anja Frohlich has worked alongside notable colleagues, including Hannelore Rosch and Jose Flavio Ramalho-Ortigao. These collaborations have enriched her research and expanded the impact of her innovations in the scientific community.
Conclusion
Anja Frohlich's contributions to oligonucleotide technology exemplify her commitment to advancing therapeutic solutions. Her innovative work continues to influence the field and holds promise for future developments in nucleic acid therapies.